Skip to main content
. 2022 Mar 1;51:102273. doi: 10.1016/j.redox.2022.102273

Fig. 3.

Fig. 3

Effects of CDRE consumption on glucose dysmetabolism associated to a HFM in healthy participants. Incremental AUC for plasma glucose (A), insulin (B), GIP (C), GLP-1 (D), and GLP-2 (E) determined during the 5 h following the consumption of a HFM and placebo or CDRE. Results are shown as means ± SE. Units for incremental AUC/5 h are for glucose, mg/dL; insulin, mU/L; GIP, μM; GLP-1 and GLP-2, μg/mL. *Significantly different from placebo (p < 0.05, one-way ANOVA).